Novartis Ag (NVS) Leases (2019 - 2025)

Novartis Ag's Leases history runs 7 years deep, the most recent figure standing at $1.4 billion for Q2 2025.

• In Q2 2025, Leases rose 5.7% year-over-year to $1.4 billion; the TTM figure through Jun 2025 stood at $1.4 billion (up 5.7% YoY), while the FY2024 annual figure was $47.0 million, up 193.75% from the prior year.
• Leases came in at $1.4 billion for Q2 2025 at Novartis Ag, up from $47.0 million in the prior quarter.
• In the past five years, Leases ranged from a high of $68.7 billion in Q2 2021 to a low of $12.0 million in Q1 2022.
• A 5-year average of $9.5 billion and a median of $133.0 million in 2023 frame the typical range for Leases.
• Across the five-year window, Leases surged 4778.12% in 2021 and sank 98.88% in 2023, its largest moves.
• Novartis Ag's Leases stood at $1.6 billion in 2021, then slipped by 8.33% to $1.4 billion in 2022, then tumbled by 98.88% to $16.0 million in 2023, then soared by 193.75% to $47.0 million in 2024, then soared by 2976.6% to $1.4 billion in 2025.
• According to Business Quant data, Leases over the past three periods registered $1.4 billion, $47.0 million, and $45.0 million for Q2 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison